Day: February 17, 2026
Pompe Disease Gene Therapy 2024: FDA Approval Status, Cost With Insurance, Long-Term Efficacy & Eligibility Guide
Per March 2024 FDA, CDC, and National Organization for Rare Disorders (NORD) data, no Pompe disease gene therapy has full US approval yet, with 3 active phase 1/2 trials open for eligible patients right now. This 2024 buying guide breaks down premium FDA-vetted gene therapy vs counterfeit unregulated overseas models, including the latest approval timelines,
Texas SME Cyber Insurance 2024: Mandatory Rules, SB 2610 Safe Harbor, Costs & Do You Need Coverage?
October 2024 | Google Partner-certified Texas small business risk advisory | Licensed Texas Insurance Producer. Per 2024 Texas Department of Information Resources, Gallagher Small Business Insurance Report, and Texas Attorney General data, 62% of breached Texas SMEs shut down within 6 months without appropriate coverage. This 2024 Texas SME cyber insurance buying guide compares premium